The Confederation of Indian Industry (CII) is holding its sixth edition of the international flagship summit in Mumbai on Wednesday, with the support of a number of associations from the pharma industry.
Union health minister Dr Anbumani Ramadoss will deliver the keynote address in the Pharma Summit 2008, to be attended by DCGI Dr Surinder Singh. The event will witness the release of CII and KPMG report on "India Pharma Inc. - An Emerging Global Pharma Hub".
Announcing the summit, Hikal MD and summit vice-chairman Jai Hiremath said, the aim of the summit is to identify the emerging opportunities in the industry and prepare itself to meet the new challenges in capturing these opportunities. "The Summit will also focus on the specific sub-sectors such as CRAMS, Clinical research and related services, Discovery research, Biotechnology and Global generics opportunities that will enable Indian Pharmaceutical industry to emerge as the global pharma hub," he said.
The summit is expected to bring together crosscurrents of opinions, views and ideas inherent to the industry and build a common platform for it. Summit is supported by Bulk Drug Manufacturers Association (BDMA), Indian Chemical Council (ICC), Indian Drug Manufacturer's Association (IDMA), Indo French Chamber of Commerce & Industry (IFCCI), and Organization of Pharmaceutical Producers of India (OPPI).
Some of the Key speakers at the event would be K Satish Reddy of Dr Reddy's Laboratories Ltd , Banmali Agrawala, Habil F Khorakiwala of Wockhardt Ltd, Roger Metelerkamp from KPMG, United Kingdom, Ranjit Shahani of Novartis India Ltd, Dr Swati Piramal of Piramal Healthcare Ltd, Satish Khanna from Lupin Ltd, Dr J M Khanna of Jubilant Organosys Ltd, Suneela Thatte from Quintiles Research (India) Pvt. Ltd, Dr B Gopalan of Orchid Pharmaceuticals Ltd, Dr Villoo Morawala Patell of Avesthagen Ltd, S V Veerramani of IDMA, and Jagdish V Dore of Matrix Laboratories Ltd.